Target intelligence / Profile preview

Torsin-1A (TOR1A)

Target
TOR1A
Molecular classification
AAA+ ATPase, Chaperone, Enzyme, Other
01

Overview

Torsin-1A is an AAA+ ATPase chaperone protein predominantly found in the endoplasmic reticulum and nuclear envelope, encoded by the TOR1A gene on human chromosome 9[1][2][3][4][5]. It is involved in protein folding and processing, quality control of misfolded proteins, regulation of synaptic vesicle trafficking, and maintenance of nuclear envelope integrity, particularly in neurons[2][3][5]. Mutations, most notably the ΔGAG deletion, in TOR1A cause early-onset isolated dystonia (DYT1), a neurological disorder characterized by involuntary muscle contractions and abnormal movements[1][2][3]. Torsin-1A is especially important for neuronal function in dopamine-producing regions such as the substantia nigra[3]. While central to inherited dystonias, interactions with drugs and biomarker usage remain unclear. The gene product is a potential therapeutic target for neurogenetic movement disorders, but disruption of its activity risks exacerbating neurodegeneration or movement abnormalities[2][3].

Other names
Dystonia 1 proteinDYT1DQ2Torsin family 1 member AtorsinAtorsin-1ATATORADystonia 1Torsion (autosomal dominant; torsin A)Torsin ATPase-1AAMC5TOR1A_HUMAN
02

Biological functions

Protein foldingChaperone activityProtein degradationSynaptic vesicle traffickingQuality control of protein foldingRegulation of nuclear envelope integrityRegulation of subcellular localizationRegulation of cell movement
03

Disease associations

Neurodegenerative diseaseDystoniaEarly-onset isolated dystoniaArthrogryposis multiplex congenitaOther movement disorders
04

Safety considerations

Potential for movement disorders (dystonia) upon inhibition or dysfunctionmutations cause neurodegenerative diseasetherapeutic targeting could affect neuronal protein processing and synaptic function

Beyond the preview

Go deeper on Torsin-1A (TOR1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torsin-1A (TOR1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call